| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8241054 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 8 Pages |
Abstract
The maximal tolerated dose of MGd with radiotherapy for glioblastoma multiforme in this study was 5 mg/kg/d for 22 doses (daily for 2 weeks, then three times weekly). The baseline survival calculations suggest progression to Phase II trials is appropriate, with the addition of MGd to radiotherapy with concurrent and adjuvant temozolomide.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Judith M. M.D., Ph.D., Wendy M.S., Jeffrey R. Ph.D., Genevieve Ph.D., Thyra J. M.D., Minesh M.D., Walter M.D., F.A.C.R., See-Chun M.D.,